BEAM
Price
$18.57
Change
+$1.58 (+9.29%)
Updated
Jun 6 closing price
Capitalization
1.87B
66 days until earnings call
BHVN
Price
$17.03
Change
+$0.83 (+5.12%)
Updated
Jun 6 closing price
Capitalization
1.74B
58 days until earnings call
Interact to see
Advertisement

BEAM vs BHVN

Header iconBEAM vs BHVN Comparison
Open Charts BEAM vs BHVNBanner chart's image
Beam Therapeutics
Price$18.57
Change+$1.58 (+9.29%)
Volume$3.9M
Capitalization1.87B
Biohaven
Price$17.03
Change+$0.83 (+5.12%)
Volume$1.47M
Capitalization1.74B
BEAM vs BHVN Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. BHVN commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and BHVN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (BEAM: $18.58 vs. BHVN: $17.03)
Brand notoriety: BEAM and BHVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 176% vs. BHVN: 63%
Market capitalization -- BEAM: $1.87B vs. BHVN: $1.74B
BEAM [@Biotechnology] is valued at $1.87B. BHVN’s [@Biotechnology] market capitalization is $1.74B. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileBHVN’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • BHVN’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than BHVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while BHVN’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 4 bearish.
  • BHVN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both BEAM and BHVN are a good buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а +17.34% price change this week, while BHVN (@Biotechnology) price change was +14.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

BHVN is expected to report earnings on Aug 04, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.87B) has a higher market cap than BHVN($1.74B). BEAM YTD gains are higher at: -25.101 vs. BHVN (-54.404). BEAM has higher annual earnings (EBITDA): -399.03M vs. BHVN (-877.26M). BEAM has more cash in the bank: 1.22B vs. BHVN (486M). BHVN has less debt than BEAM: BHVN (36.6M) vs BEAM (158M). BEAM has higher revenues than BHVN: BEAM (63.6M) vs BHVN (0).
BEAMBHVNBEAM / BHVN
Capitalization1.87B1.74B107%
EBITDA-399.03M-877.26M45%
Gain YTD-25.101-54.40446%
P/E RatioN/AN/A-
Revenue63.6M0-
Total Cash1.22B486M251%
Total Debt158M36.6M432%
FUNDAMENTALS RATINGS
BHVN: Fundamental Ratings
BHVN
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMBHVN
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
74%
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 9 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
69%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRIEX26.70N/A
N/A
Nuveen International Eq Idx Retire
ALPCX10.31N/A
N/A
American Century Focused Lg Cap Val C
SMDVX17.78N/A
N/A
Hartford Schroders US MidCap Opps A
EICCX17.43N/A
N/A
EIC Value C
GMJPX12.01N/A
N/A
Goldman Sachs Real Estate Securities P

BHVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with BEAM. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHVN
1D Price
Change %
BHVN100%
+5.12%
BEAM - BHVN
50%
Loosely correlated
+9.26%
CGON - BHVN
49%
Loosely correlated
+1.05%
SYRE - BHVN
49%
Loosely correlated
+2.11%
RVMD - BHVN
47%
Loosely correlated
+2.21%
OCUL - BHVN
47%
Loosely correlated
+6.62%
More